Grifols SA B (XMAD:GRF.P)
European company
Share Price Chart
- Chart currently unavailable -
Market Info - GRF.P
- Market Open Price0.00
- Previous Close0.00
- Volume-
- 52w Low/High-
- Last Trade Price0.00
- Bid/Ask Price0.00
Company Info - GRF.P
- Market Cap€15.143bn
- SymbolXMAD:GRF.P
- IndustryHealthcare
- SectorDrug Manufacturers - General
- Currency
- ISINES0171996095
Company Profile
As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and the firm's bioscience business contributed 78% of sales in 2019. Grifols also has smaller segments including diagnostics, hospital supplies, and biosupplies. Diagnostics is now roughly 14% of revenue following the Novartis and Hologic deals.Grifols SA is a pharmaceutical company. It primarily collects the liquid portion of human blood called plasma and then manufactures and sells plasma-derived products globally. It also operates diagnostics, hospital supplies, and raw materials businesses.
Latest GRF.P news
Currently there for this company. Visit our news hub for other news .